Aptevo extends shareholder rights agreement Final Expiration Date to Oct 29, 2026

Aptevo Therapeutics Inc.

Amendment No. 5 to Rights Agreement extends Final Expiration Date from Nov 2025 to Oct 29, 2026.
Rights originally adopted Nov 8, 2020; no other terms of the agreement were changed.
Extension covers contingent rights to purchase 1/1000th of Series A Junior Participating Preferred Stock.
Broadridge Corporate Issuer Solutions remains rights agent.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.